Analystreport

Kiniksa Pharmaceuticals Ltd (NASDAQ: KNSA) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $31.00 price target on the stock.

Kiniksa Pharmaceuticals, Ltd. - Class A  (KNSA) 
Last kiniksa pharmaceuticals, ltd. - class a earnings: 8/12 04:02 pm Check Earnings Report